Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Abdominal Aortic Aneurysm Drug Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4309536
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 137 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Abdominal Aortic Aneurysm Drug Market Status and Forecast (2016-2027)
      • 1.3.2 Global Abdominal Aortic Aneurysm Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Abdominal Aortic Aneurysm Drug Supply by Company

    • 2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by Company
    • 2.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Company
    • 2.3 Global Abdominal Aortic Aneurysm Drug Price by Company
    • 2.4 Abdominal Aortic Aneurysm Drug Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Abdominal Aortic Aneurysm Drug Market Status by Category

    • 3.1 Abdominal Aortic Aneurysm Drug Category Introduction
      • 3.1.1 BSN-908
      • 3.1.2 Canakinumab
      • 3.1.3 CT-2009
      • 3.1.4 Ticagrelor
      • 3.1.5 Others
    • 3.2 Global Abdominal Aortic Aneurysm Drug Market by Category
      • 3.2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by Category (2016-2021)
      • 3.2.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Category (2016-2021)
      • 3.2.3 Global Abdominal Aortic Aneurysm Drug Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Abdominal Aortic Aneurysm Drug Market Status by End User/Segment

    • 4.1 Abdominal Aortic Aneurysm Drug Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Others
    • 4.2 Global Abdominal Aortic Aneurysm Drug Market by End User/Segment
      • 4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Abdominal Aortic Aneurysm Drug Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Abdominal Aortic Aneurysm Drug Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Abdominal Aortic Aneurysm Drug Market Status by Region

    • 5.1 Global Abdominal Aortic Aneurysm Drug Market by Region
      • 5.1.1 Global Abdominal Aortic Aneurysm Drug Sales Volume by Region
      • 5.1.2 Global Abdominal Aortic Aneurysm Drug Sales Value by Region
    • 5.2 North America Abdominal Aortic Aneurysm Drug Market Status
    • 5.3 Europe Abdominal Aortic Aneurysm Drug Market Status
    • 5.4 Asia Pacific Abdominal Aortic Aneurysm Drug Market Status
    • 5.5 Central & South America Abdominal Aortic Aneurysm Drug Market Status
    • 5.6 Middle East & Africa Abdominal Aortic Aneurysm Drug Market Status

    6 North America Abdominal Aortic Aneurysm Drug Market Status

    • 6.1 North America Abdominal Aortic Aneurysm Drug Market by Country
      • 6.1.1 North America Abdominal Aortic Aneurysm Drug Sales Volume by Country (2016-2021)
      • 6.1.2 North America Abdominal Aortic Aneurysm Drug Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Abdominal Aortic Aneurysm Drug Market Status

    • 7.1 Europe Abdominal Aortic Aneurysm Drug Market by Country
      • 7.1.1 Europe Abdominal Aortic Aneurysm Drug Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Abdominal Aortic Aneurysm Drug Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Abdominal Aortic Aneurysm Drug Market Status

    • 8.1 Asia Pacific Abdominal Aortic Aneurysm Drug Market by Country
      • 8.1.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Abdominal Aortic Aneurysm Drug Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Abdominal Aortic Aneurysm Drug Market Status

    • 9.1 Central & South America Abdominal Aortic Aneurysm Drug Market by Country
      • 9.1.1 Central & South America Abdominal Aortic Aneurysm Drug Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Abdominal Aortic Aneurysm Drug Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Abdominal Aortic Aneurysm Drug Market Status

    • 10.1 Middle East & Africa Abdominal Aortic Aneurysm Drug Market by Country
      • 10.1.1 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Abdominal Aortic Aneurysm Drug Manufacturing Cost Analysis
    • 11.5 Abdominal Aortic Aneurysm Drug Sales Channel and Distributors Analysis
      • 11.5.1 Abdominal Aortic Aneurysm Drug Sales Channel
      • 11.5.2 Abdominal Aortic Aneurysm Drug Distributors
    • 11.6 Abdominal Aortic Aneurysm Drug Downstream Major Buyers

    12 Global Abdominal Aortic Aneurysm Drug Market Forecast by Category and by End User/Segment

    • 12.1 Global Abdominal Aortic Aneurysm Drug Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Abdominal Aortic Aneurysm Drug Forecast by Category
      • 12.2.1 Global Abdominal Aortic Aneurysm Drug Sales Volume Forecast by Category
      • 12.2.2 Global Abdominal Aortic Aneurysm Drug Sales Value Forecast by Category
      • 12.2.3 Global Abdominal Aortic Aneurysm Drug Price Forecast by Category
    • 12.3 Global Abdominal Aortic Aneurysm Drug Forecast by End User/Segment
      • 12.3.1 Global Abdominal Aortic Aneurysm Drug Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Abdominal Aortic Aneurysm Drug Sales Value Forecast by End User/Segment
      • 12.3.3 Global Abdominal Aortic Aneurysm Drug Price Forecast by End User/Segment

    13 Global Abdominal Aortic Aneurysm Drug Market Forecast by Region/Country

    • 13.1 Global Abdominal Aortic Aneurysm Drug Market Forecast by Region (2022-2027)
      • 13.1.1 Global Abdominal Aortic Aneurysm Drug Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Abdominal Aortic Aneurysm Drug Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vida Therapeutics Inc.
      • 14.1.1 Company Information
      • 14.1.2 Abdominal Aortic Aneurysm Drug Product Introduction
      • 14.1.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Novartis AG
      • 14.2.1 Company Information
      • 14.2.2 Abdominal Aortic Aneurysm Drug Product Introduction
      • 14.2.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Carolus Therapeutics, Inc.
      • 14.3.1 Company Information
      • 14.3.2 Abdominal Aortic Aneurysm Drug Product Introduction
      • 14.3.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 AstraZeneca Plc
      • 14.4.1 Company Information
      • 14.4.2 Abdominal Aortic Aneurysm Drug Product Introduction
      • 14.4.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Abdominal Aortic Aneurysm Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Abdominal Aortic Aneurysm Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        BSN-908
        Canakinumab
        CT-2009
        Ticagrelor
        Others

        Segmented by End User/Segment
        Hospital
        Clinic
        Others

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Vida Therapeutics Inc.
        Novartis AG
        Carolus Therapeutics, Inc.
        AstraZeneca Plc


        Summary:
        Get latest Market Research Reports on Abdominal Aortic Aneurysm Drug. Industry analysis & Market Report on Abdominal Aortic Aneurysm Drug is a syndicated market report, published as Dynamics in Post-pandemic Global Abdominal Aortic Aneurysm Drug Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Abdominal Aortic Aneurysm Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,980.00
        $4,470.00
        $5,960.00
        2,109.84
        3,164.76
        4,219.68
        2,449.56
        3,674.34
        4,899.12
        325,654.40
        488,481.60
        651,308.80
        218,493.60
        327,740.40
        436,987.20
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report